Publications by authors named "Ivo Bernat"

Article Synopsis
  • Researchers studied two access methods for heart procedures—transradial access (TRA) and transfemoral access (TFA)—to see which one leads to lower mortality and bleeding in coronary artery disease patients.
  • A meta-analysis of data from 21,600 patients across 7 clinical trials found that TRA significantly reduced all-cause mortality (1.6% vs. 2.1%) and major bleeding (1.5% vs. 2.7%) compared to TFA.
  • The benefits of TRA were especially notable in patients with moderate or severe anemia, with TRA linked to a 24% reduction in death risk and a 51% reduction in bleeding
View Article and Find Full Text PDF
Article Synopsis
  • The study compares distal radial access (DRA) and conventional transradial access (TRA) for coronary procedures, focusing on the incidence of radial artery occlusion (RAO), a common complication of TRA.
  • In a trial with 1,307 patients, results showed no significant difference in RAO rates between the two methods (0.91% for TRA vs 0.31% for DRA), but DRA had a higher crossover rate (7.4% vs 3.5%) and shorter hemostasis time (153 minutes vs 180 minutes).
  • Both methods resulted in similar rates of overall bleeding and complications, suggesting that DRA could be an effective alternative to
View Article and Find Full Text PDF

Background: It is unclear whether more effective forms of thrombus removal than current aspiration catheters would lead to improved outcomes. We sought to evaluate the prognostic role of residual thrombus burden (rTB), after manual thrombectomy, in patients undergoing primary percutaneous coronary intervention with routine manual thrombectomy in the TOTAL trial (Thrombectomy Versus PCI Alone).

Methods: This is a single-arm analysis of patients from the TOTAL trial who underwent routine manual aspiration thrombectomy.

View Article and Find Full Text PDF

The aim of this study was to evaluate the patency of the proximal and distal radial artery after coronary procedures performed via the distal radial artery (DRA). Ultrasound (US) as the most reliable method was used to diagnose radial artery occlusions (RAO). We evaluated 115 patients who underwent catheterization via distal radial access (dTRA).

View Article and Find Full Text PDF

Background: Transradial access (TRA) has become the default access method for coronary diagnostic and interventional procedures. As compared to transfemoral access, TRA has been shown to be safer, cost-effective and more patient-friendly. Radial artery occlusion (RAO) represents the most frequent complication of TRA, and precludes future coronary procedures through the radial artery, the use of the radial artery as a conduit for coronary artery bypass grafting or as arteriovenous fistula for patients on hemodialysis.

View Article and Find Full Text PDF

Background: Despite the enormous benefits of radial access, this route is associated with a risk of radial artery occlusion (RAO).

Objective: We compared the incidence of RAO in patients undergoing transradial coronary angiography and intervention after short versus prolonged hemostasis protocol. Also we assessed the efficacy of rescue 1-hour ipsilateral ulnar artery compression if RAO was observed after hemostasis.

View Article and Find Full Text PDF

The transradial approach is recommended as a first choice in coronary catheterizations and interventions, for among other reasons, the reduction in the number of local complications. A head-to-head comparison of the reverse Barbeau test (RBT) and duplex ultrasonography (DUSG) for the detection of post-procedural radial artery patency and occlusion has not yet been evaluated. In 500 patients from our same-day discharge program (age 65 ± 9.

View Article and Find Full Text PDF

Transradial access (TRA) is increasingly used worldwide for percutaneous interventional procedures and associated with lower bleeding and vascular complications than transfemoral artery access. Radial artery occlusion (RAO) is the most frequent post-procedural complication of TRA, restricting the use of the same radial artery for future procedures and as a conduit for coronary artery bypass graft. The authors review recent advances in the prevention of RAO following percutaneous TRA diagnostic or interventional procedures.

View Article and Find Full Text PDF

Objectives: We sought to compare outcomes with radial vs femoral approach in female patients undergoing coronary angiography.

Background: Women undergoing cardiac procedures have increased risk of bleeding and vascular complications, but are under-represented in randomized clinical trials (RCTs) involving coronary angiography.

Methods: We performed a meta-analysis of RCTs comparing outcomes in women undergoing angiography with radial vs femoral approaches.

View Article and Find Full Text PDF

Background: Routine thrombus aspiration in patients undergoing primary percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI) does not improve clinical outcomes. However, there is remaining uncertainty about the potential benefit in those patients with high thrombus burden, where there is a biological rationale for greater benefit.

Objectives: The purpose of this study was to evaluate the benefit of thrombus aspiration among STEMI patients with high thrombus burden.

View Article and Find Full Text PDF

Background: During transradial (TR) access, it remains unclear whether differences in baseline patients characteristics and hemostasis care impact the rate of radial artery occlusion (RAO). We sought to compare the rate of RAO after TR access with the 6 French(Fr) Glidesheath Slender (GSS6Fr, Terumo, Japan) or a standard 5 Fr sheath in Japanese and non-Japanese patients.

Methods And Results: The Radial Artery Patency and Bleeding, Efficacy, Adverse evenT (RAP and BEAT) trial randomized 1,836 patients undergoing TR coronary angiography and/or interventions to receive the GSS6Fr or the standard 5 Fr Glidesheath (GS5Fr, Terumo, Japan).

View Article and Find Full Text PDF

Aims: The 6 Fr Glidesheath Slender (GSS6Fr) is a recently developed thin-walled radial sheath with an outer diameter (OD) that is smaller than the OD of standard 6 Fr sheaths. The purpose of this trial was to clarify whether the use of this new slender sheath would result in similar rates of RAO to a standard 5 Fr sheath in unselected patients undergoing transradial (TR) coronary angiography and/or intervention, and to assess the relative importance of sheath size and haemostasis protocol on the rate of RAO.

Methods And Results: We conducted a randomised, multicentre, non-inferiority trial comparing the GSS6Fr against the standard GS5Fr in patients undergoing TR coronary angiography and/or intervention.

View Article and Find Full Text PDF

Objectives: The study sought to evaluate whether prophylactic ipsilateral ulnar artery compression during radial artery hemostasis could reduce the risk of radial artery occlusion (RAO).

Background: RAO after transradial access (TRA) is a structural complication of TRA. It limits future ipsilateral TRA and may cause transient pain.

View Article and Find Full Text PDF

Background: The aim of this study was to evaluate access-site complications in patients with ST-segment elevation myocardial infarction treated with a transradial primary percutaneous coronary intervention relative to three different P2Y12 platelet inhibitors.

Patients And Methods: We enrolled 334 consecutive patients (76.9% men, age: 59.

View Article and Find Full Text PDF
Article Synopsis
  • RAO (Radial artery occlusion) is a common issue after transradial interventions that can hinder future access and use of the radial artery as an arterial conduit.
  • A meta-analysis of 66 studies involving over 31,000 participants showed that the incidence of RAO can range from <1% to 33%, influenced by the timing of assessments and various factors such as heparin dosage and compression time.
  • To reduce the risk of RAO, higher doses of heparin and shorter compression times are recommended, while also considering factors like age and sheath size, although these do not consistently affect outcomes in all studies.
View Article and Find Full Text PDF

Background: Two large trials have reported contradictory results at 1 year after thrombus aspiration in ST elevation myocardial infarction (STEMI). In a 1-year follow-up of the largest randomised trial of thrombus aspiration, we aimed to clarify the longer-term benefits, to help guide clinical practice.

Methods: The trial of routine aspiration ThrOmbecTomy with PCI versus PCI ALone in Patients with STEMI (TOTAL) was a prospective, randomised, investigator-initiated trial of routine manual thrombectomy versus percutaneous coronary intervention (PCI) alone in 10,732 patients with STEMI.

View Article and Find Full Text PDF

Background: The benefit of transradial access (TRA) in patients with cardiogenic shock (CS) is uncertain. We sought to determine the benefits of TRA in patients with CS undergoing coronary angiography/intervention.

Methods: MEDLINE, Embase, Cochrane Central, and electronic databases were searched for studies that assessed the following: (1) patients with CS who underwent percutaneous coronary intervention (PCI) and (2) the association between choice of arterial access, 30-day all-cause mortality, and 30-day major adverse cardiac and cerebral events (MACCEs) using random-effects model.

View Article and Find Full Text PDF

Background: During primary percutaneous coronary intervention (PCI), manual thrombectomy may reduce distal embolization and thus improve microvascular perfusion. Small trials have suggested that thrombectomy improves surrogate and clinical outcomes, but a larger trial has reported conflicting results.

Methods: We randomly assigned 10,732 patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary PCI to a strategy of routine upfront manual thrombectomy versus PCI alone.

View Article and Find Full Text PDF

Assessment of the treatment procedures and their results is increasingly important in current medicine. The emphasis is put on an effective use of the health technologies (HTA). Unlike randomised studies, which involve strictly selected groups of patients who meet inclusion and exclusion criterias, the multicentre clinical registries provide a real-life picture of the treatment safety and effectiveness.

View Article and Find Full Text PDF

Despite the extensive armamentarium of antihypertensive medication available, the control of hypertension remains poor. Therefore any possibilities of non-pharmacological treatment of resistant hypertension are welcome. Recently, close attention was paid to renal denervation.

View Article and Find Full Text PDF